Improving brain intervention planning using vascular mapping
Official title: Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping
Run by University Hospital, Ghent · NCT06588543 · Data updated 2026-11-12
This study is testing new ways to plan brain surgeries for aneurysms and AVMs to make them safer and more effective by using advanced mapping and computer models.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | August 13, 2024 |
| Main results expected | December 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT06588543 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with an aneurysm or arteriovenous malformation who are undergoing endovascular embolization or coiling.
✕Probably not a fit
Patients who are not undergoing imaging during their procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on enhancing the safety and efficiency of endovascular procedures for treating brain aneurysms and arteriovenous malformations (AVMs) through innovative preoperative planning methodologies. By utilizing advanced mapping of cerebral vasculature and creating computational fluid dynamics (CFD) and artificial intelligence (AI) models, the study aims to simulate blood flow and improve catheter navigation. This approach seeks to reduce the risk of complications and radiation exposure during procedures, ultimately leading to faster and more accurate interventions.
Why it matters
Potential benefit: If successful, this study could lead to safer and more effective endovascular treatments for patients with brain aneurysms and AVMs.
How similar studies have gone: Other studies have shown promise in using advanced imaging and modeling techniques for similar endovascular procedures, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects who are diagnosed with aneurysm or arteriovenous malformation * Subjects who are treated (or will be treated) with endovascular embolization and/or arteriovenous coiling * During and before/after the subject's intervention, medical images (MRI, 3D rotational angiography, DSA) were collected of the cerebral arterial vascular tree (which can be used to develop patient-specific models), including catheter location and use of contrast fluid to visualize the cerebral to make the arterial tree more visible. Exclusion Criteria: -Procedures during which no imaging was performed
Where it's running
-
University Hospital Ghent
Ghent, Belgium Recruiting
Study contacts
- Study coordinator: Peter Vanlangenhove, Prof. Dr.
- Email: peter.vanlangenhove@uzgent.be
- Phone: +32 9 3323112
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flow Diverter Stent for Intracranial Aneurysm in China
This study tests a novel flow diverter stent to treat intracranial aneurysms in adults and follows patients through treatment and follow-up.
-
Real-World Experience With the WEB Device for Intracranial Aneurysms
This study tests how well the Woven EndoBridge device works in routine treatment of intracranial aneurysms in China across multiple centers.
-
Choydar flow-directed mesh stent for unruptured brain aneurysms
This trial tests the Choydar flow-directed mesh stent to see if it is safe and works for people with unruptured intracranial aneurysms in the internal carotid or vertebral arteries.
-
Pivotal test of the Silk Vista Baby Flow Diverter for unruptured brain aneurysms
This study tests whether the Silk Vista Baby flow diverter can safely and effectively treat a single unruptured intracranial aneurysm in adults 22–80 years old.
-
Pipeline Vantage post-approval safety and outcomes for intracranial aneurysm treatment
This project will test whether the Pipeline Vantage embolization device with Shield Technology is safe and effective for adults treated for intracranial aneurysms.
-
Collecting real-life data on endovascular treatments for brain aneurysms
This study is collecting real-life information on how safe and effective a specific type of device is for treating brain aneurysms in patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.